Horn Kinney
CHIEF BUSINESS OFFICER
Horn Kinney has filed 3 SEC Form 4 filings (6 transaction rows) across 1 company, with disclosures dating back to 2026. 3 of those filings fall inside the rolling window. Most recent filing: Aug 6, 2026.
On the most recent filing, Horn Kinney is listed as CHIEF BUSINESS OFFICER at Immunome Inc. Inside the rolling window, Horn Kinney reported no open-market purchases and 2 open-market sales totaling $2.3M in IMNM. The largest disclosed transaction in the window is a sale of 90,616 IMNM shares on Aug 4, 2026, worth $2.3M.
Companies traded
Other insiders at IMNM
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$2.3M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Horn Kinney made?
Horn Kinney has filed 3 SEC Form 4 filings (6 transaction rows) across 1 company since 2026.
Which companies does Horn Kinney trade?
Horn Kinney has filed SEC Form 4 disclosures for 1 company, including IMNM.
When was Horn Kinney's most recent SEC Form 4 filing?
Horn Kinney's most recent SEC Form 4 filing on Tracefour is dated Aug 6, 2026.
What is Horn Kinney's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Horn Kinney is listed as CHIEF BUSINESS OFFICER.
What is Horn Kinney's total buy and sell value in the current window?
Inside the rolling retention window, Horn Kinney bought $0 and sold $2.3M based on SEC Form 4 filings.
What was Horn Kinney's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 90,616 IMNM shares on 2026-08-04, worth $2.3M, per SEC Form 4 filings.